Zardaverine (Synonyms: 扎达维林)

Zardaverine是一种口服有效的和具有选择性的 PDE3/4 抑制剂 (IC50)=0.58 uM/0.17 uM),具有强大的支气管扩张活性。Zardaverine 还可选择性地抑制 HCC 细胞增殖,并诱导细胞凋亡和周期停滞 (G0/G1 期)。Zardaverine 具有较好的抗肿瘤潜力,并且在哮喘中的支气管松弛和减少炎症方面均有效。
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
生物活性
纯度 & 产品资料
参考文献
生物活性 | Zardaverine is an orally active and selective PDE3/4 inhibitor (IC50)=0.58 uM/0.17 uM) with potent bronchodilator activity. Zardaverine also selectively inhibits the proliferation of HCC cells and induces apoptosis and cycle arrest (G0/G1 phase). Zardaverine has good antitumor potential and is effective in both bronchial relaxation and reduction of inflammation in asthma[1][2][3]. | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target |
| ||||||||||||||||
体外研究 (In Vitro) | Zardaverine (0-30 µM; 72 h) selectively inhibits the growth of human HCC cells in vitro[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation Assay[1]
| ||||||||||||||||
体内研究 (In Vivo) | Zardaverine (60, 200 mg/kg; p.o.; single daily for 14 days) inhibits the growth of human Bel-7402 xenografts in mice[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
分子量 | 268.22 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C12H10F2N2O3 | ||||||||||||||||
CAS 号 | |||||||||||||||||
中文名称 | 扎达维林 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 25 mg/mL (93.21 mM; Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 |